Cart

This article PDF is available for purchase only. PDFs are free for members! Become a member and save today

Remove item Thumbnail image Product Price Quantity Subtotal
× Placeholder The Retinoid X Receptor Agonist Bexarotene Relieves Positive Symptoms of Schizophrenia: A 6-Week, Randomized, Double-Blind, Placebo-Controlled Multicenter Trial PDF $40.00
$40.00
× Placeholder Are Illness Concepts a Powerful Predictor of Adherence to Prophylactic Treatment in Bipolar Disorder? PDF $40.00
$40.00
× Placeholder Diagnosis and Management of Depression in 3 Countries: Results From a Clinical Vignette Factorial Experiment PDF $40.00
$40.00
× Placeholder Bupropion Sustained Release Added to Group Support for Smoking Cessation in Schizophrenia: A New Randomized Trial and a Meta-Analysis PDF $40.00
$40.00
× Placeholder Stimulant Treatment Trajectories Are Associated With Neural Reward Processing in Attention-Deficit/Hyperactivity Disorder PDF $40.00
$40.00

Instead of purchasing individual articles, subscribe to our membership plan and get unlimited access to all article PDFs from both of our journals.


Join Now

Cart totals

Subtotal $200.00
Total $200.00
Proceed to checkout

Consensus Report on XT Use in Practice

Figure: Graphic promoting Consensus Report on Xanomeline-Trospium; colorful net design shown with JCP logo in lower left.

Subscribe to read
more articles

Subscribe